Insight Molecular Diagnostics (IMDX) Deferred Taxes (2020 - 2021)
Insight Molecular Diagnostics (IMDX) posted Deferred Taxes of $97000.0 for Q4 2021, up 105.41% sequentially from -$1.8 million in Q2 2021, and up 161.01% YoY from $37163.9 in Q4 2020.
Insight Molecular Diagnostics (IMDX) Deferred Taxes (2020 - 2021) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 2 years of Deferred Taxes data on file, last reported at $97000.0 in Q4 2021.
- Quarterly Deferred Taxes rose 161.01% year-over-year to $97000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$9.3 million (down 638.52% YoY) and the FY2021 annual result came in at -$9.3 million, down 638.52% from the prior year.
- Deferred Taxes rose to $97000.0 in Q4 2021 per IMDX's latest filing, from -$1.8 million in the prior quarter.
- The five-year high for Deferred Taxes was $97000.0 in Q4 2021, with the low at -$7.6 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -1.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -258.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 13.89 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 32.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -38.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 3.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -1.99 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 97,000.00 |
| Jun 30, 2021 | -1.79 Mn |
| Mar 31, 2021 | -7.56 Mn |
| Dec 31, 2020 | -159,000.00 |
| Mar 31, 2020 | -1.10 Mn |